1.
David V. Gauvin, Joshua Yoder, Rachel L. Tapp, Phaedra I. Cole, Phaedra I. Cole. Defining “Best Practices” for Critical Endpoints in Preclinical Screening of New Chemical Entities for Ototoxicity Liability. OOJ [Internet]. 2016 May 9 [cited 2026 Aug. 26];2(2):58-69. Available from: https://openventio.us/index.php/OOJ/article/view/2437